Evidence map›Paper›PMID 29521846›Full record

ArticleInternational journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists2019

International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group.

Kathleen R Cho, Kumarasen Cooper, Sabrina Croce, Bojana Djordevic, Simon Herrington, Brooke Howitt, Pei Hui, Philip Ip, Martin Koebel, Sigurd Lax and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Colombian consensus for the molecular diagnosis of endometrial cancerRevista colombiana de obstetricia y ginecologia · 2024
    Guideline
  2. Gender bias in shared decision-making among cancer care guidelines: A systematic review.Health expectations : an international journal of public participation in health care and health policy · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.Virchows Archiv : an international journal of pathology · 2021
    Guideline
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Endometrial cancer: predictors and oncological safety of tumor tissue manipulation.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  15. Article
  16. Article
  17. Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kathleen R ChoMD Anderson Cancer Center, Houston, Texas (R.B., A.Y., A.M.) University of Michigan Medical School, Ann Arbor, Michigan (K.R.C.) Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (K.C.) Bergonie Institute, Bordeaux, France (S.C.) The Ottawa Hospital, University of Ottawa, Ottawa (B.D.) Toronto General Hospital, Toronto (P.S., B.C.), Ontario Department of Pathology, University of Calgary, Calgary, Alberta (M.K.), Canada Edinburgh Cancer Research Centre, Edinburgh (S.H.) Belfast Health and Social Care Trust, Belfast (W.G.M.), UK Brigham and Women's Hospital (B.H., B.J.Q.) Massachusetts General Hospital, Harvard University (E.O.), Boston, Massachusetts Yale New Haven Hospital, New Haven, Connecticut (P.H., V.P.) Department of Pathology, University of Hong Kong, Hong Kong, China (P.I.) Department of Pathology, Medical University of Graz, Graz, Austria (S.L.) Bellvitge University Hospital, IDIBELL, Barcelona (A.V., X.M.G.) Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLLEIDA, Lleida (X.M.G.), CIBERONC, Spain Weill Cornell Medical College, New York, New York (L.H.E.) Stanford University Medical Center, Stanford, California (T.A.L.) Johns Hopkins University School of Medicine, Baltimore, Maryland (I.M.S.).
Kumarasen Cooper
Sabrina Croce
Bojana Djordevic
Simon Herrington
Brooke Howitt
Pei Hui
Philip Ip
Martin Koebel
Sigurd Lax
Bradley J Quade
Patricia Shaw
August Vidal
Anna Yemelyanova
Blaise Clarke
Lora Hedrick Ellenson
Teri A Longacre
Ie-Ming Shih
W Glenn McCluggage
Anais Malpica
Esther Oliva
Vinita Parkash
Xavier Matias-Guiu

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
6 · The paper itself

Abstract

The aim of this article is to propose guidelines and recommendations in problematic areas in pathologic reporting of endometrial carcinoma (EC) regarding special techniques and ancillary studies. An organizing committee designed a comprehensive survey with different questions related to pathologic features, diagnosis, and prognosis of EC that was sent to all members of the International Society of Gynecological Pathologists. The special techniques/ancillary studies group received 4 different questions to be addressed. Five members of the group reviewed the literature and came up with recommendations and an accompanying text which were discussed and agreed upon by all members of the group. Twelve different recommendations are made. They address the value of immunohistochemistry, ploidy, and molecular analysis for assessing prognosis in EC, the value of steroid hormone receptor analysis to predict response to hormone therapy, and parameters regarding applying immunohistochemistry and molecular tests for assessing mismatch deficiency in EC.

Indexed as

Endometrial NeoplasmsFemaleGynecologyHumansImmunohistochemistryPathologistsPathology, MolecularPloidiesPractice Guidelines as TopicPrognosisSocieties, Medical

Identifiers

PMID29521846
PMCPMC6296838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.